CI Investments Inc Portfolio holdings
AUM
$26.6B
1-Year Return
24.61%
This Quarter Return
+13.6%
1 Year Return
+24.61%
3 Year Return
+101.34%
5 Year Return
+166.59%
10 Year Return
+369.6%
AUM
$19.3B
AUM Growth
+$1.41B
(+7.9%)
Cap. Flow
-$797M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
28.05%
Holding
1,344
New
50
Increased
548
Reduced
617
Closed
80
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$210M |
| 2 |
Franklin FTSE Japan ETF
FLJP
|
+$111M |
| 3 |
Ventas
VTR
|
+$106M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$93.8M |
| 5 |
McDonald's
MCD
|
+$91.7M |
Top Sells
| 1 |
Eli Lilly
LLY
|
+$174M |
| 2 |
Sempra
SRE
|
+$106M |
| 3 |
Apple
AAPL
|
+$89.7M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$79.5M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$74.4M |
Sector Composition
| 1 | Technology | 23.29% |
| 2 | Financials | 13.96% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Communication Services | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bio-Rad Laboratories Class A
BIO
$7.63B
| $110K | ﹤0.01% |
341
-72
| -17% | -$23.2K |
|
802
Bank of New York Mellon
BK
$73.5B
| $110K | ﹤0.01% |
2,104
-17,088
| -89% | -$893K |
|
803
NNN REIT
NNN
$8.06B
| $109K | ﹤0.01% |
2,518
+382
| +18% | +$16.5K |
|
804
Antero Midstream
AM
$8.75B
| $108K | ﹤0.01% |
8,596
+376
| +5% | +$4.72K |
|
805
Charter Communications
CHTR
$36B
| $108K | ﹤0.01% |
278
-14
| -5% | -$5.44K |
|
806
Dow Inc
DOW
$17.2B
| $108K | ﹤0.01% |
1,973
-84
| -4% | -$4.6K |
|
807
Acadia Healthcare
ACHC
$2.01B
| $107K | ﹤0.01% |
1,381
-238
| -15% | -$18.4K |
|
808
CRISPR Therapeutics
CRSP
$4.79B
| $107K | ﹤0.01% |
1,708
-155
| -8% | -$9.71K |
|
|
SWAV
809
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $106K | ﹤0.01% |
557
-98
| -15% | -$18.7K |
|
810
Apollo Global Management
APO
$77.1B
| $105K | ﹤0.01% |
1,129
-2,002
| -64% | -$186K |
|
811
Aramark
ARMK
$9.96B
| $104K | ﹤0.01% |
3,702
-351
| -9% | -$9.86K |
|
812
Primerica
PRI
$8.74B
| $104K | ﹤0.01% |
505
-160
| -24% | -$33K |
|
813
Molson Coors Class B
TAP
$9.64B
| $104K | ﹤0.01% |
1,701
+1
| +0.1% | +$61 |
|
814
Essential Utilities
WTRG
$10.6B
| $104K | ﹤0.01% |
2,783
+768
| +38% | +$28.7K |
|
815
BioNTech
BNTX
$24.3B
| $103K | ﹤0.01% |
974
-62
| -6% | -$6.56K |
|
|
ITCI
816
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $103K | ﹤0.01% |
1,444
-248
| -15% | -$17.7K |
|
817
APA Corp
APA
$8.03B
| $102K | ﹤0.01% |
2,830
+562
| +25% | +$20.3K |
|
818
Beam Therapeutics
BEAM
$2.08B
| $102K | ﹤0.01% |
3,755
+777
| +26% | +$21.1K |
|
819
Brown-Forman Class A
BF.A
$13.2B
| $102K | ﹤0.01% |
+1,705
| New | +$102K |
|
820
IDEX
IEX
$12.1B
| $102K | ﹤0.01% |
471
-227
| -33% | -$49.2K |
|
821
Cabot Corp
CBT
$4.23B
| $101K | ﹤0.01% |
1,205
+847
| +237% | +$71K |
|
822
Permian Resources
PR
$9.83B
| $101K | ﹤0.01% |
7,393
+7,012
| +1,840% | +$95.8K |
|
823
Atlassian
TEAM
$46.1B
| $101K | ﹤0.01% |
423
-18
| -4% | -$4.3K |
|
824
Ascendis Pharma
ASND
$12B
| $100K | ﹤0.01% |
790
-158
| -17% | -$20K |
|
825
Fidelity National Information Services
FIS
$34.9B
| $99K | ﹤0.01% |
1,650
-71
| -4% | -$4.26K |
|